HEALTH officials in Liverpool, Wirral and Sefton stressed it was business as usual seeing no reason to postpone the injections.

Health authorities in Coventry launched an urgent investigation after Natalie Morton suffered a “rare but extreme reaction” after receiving the HPV1 Cervarix jab.

The batch of Cervarix allocated to the school has been quarantined as a “precautionary measure” and a post mortem examination is being carried out.

But last night Dr Paula Grey, director of public health for Liverpool confirmed: “Liverpool PCT has not suspended any sessions within the city and is taking a proactive approach to reassure schools and parents.”

And she stressed: “In the UK, about 3,000 women are diagnosed with cervical cancer every year and about 1,000 die from it.

“Being able to protect young women against this disease is a tremendous development. The vaccine has been rigorously tested and a million doses have now been given in the UK with no new risks emerging.

“The Cervarix vaccine has passed the rigorous safety testing needed for it to be used in the UK and other European countries. The vaccine has a strong safety record. Several million doses of the vaccine have been given around the world.

“As a purely precautionary measure, stocks of Cervarix vaccine from the batch that relates to this issue have been removed from nationwide stocks until the results of the investigation are available.

“However, the Department of Health has advised that the HPV vaccination programme will continue.”

A Wirral NHS spokesman added: “The vaccine has a strong safety record and the programme for young women continues to be a success and is set to continue across Wirral.

A Sefton PCT spokesman added: “After taking Department of Health advice the programme will continue.”